Publikationen

Pilchová, V. (2023). Inactivation methods to study pathogenesis and possible biomarkers for SARS-CoV-2 infection with focus on neutrophil extracellular traps. https://nbn-resolving.org/urn:nbn:de:gbv:95-119713
Details anzeigen

Pilchová, V., Gerhauser, I., Armando, F., Wirz, K., Schreiner, T., de Buhr, N., Gabriel, G., Wernike, K., Hoffmann, D., Beer, M., Baumgärtner, W., von Köckritz-Blickwede, M., & Schulz, C. (2023). Characterization of young and aged ferrets as animal models for SARS-CoV-2 infection with focus on neutrophil extracellular traps. Frontiers in Immunology, 14, Article 1283595. https://doi.org/10.3389/fimmu.2023.1283595
Details anzeigen

Pilchová, V., Prajeeth, C. K., Jendrny, P., Twele, F., Meller, S., Pink, I., Volk, H. A., Osterhaus, A., von Köckritz-Blickwede, M., & Schulz, C. (2023). β-Propiolactone (BPL)-inactivation of SARS-Co-V-2: in vitro validation with focus on saliva from COVID-19 patients for scent dog training. In 32nd Annual Meeting of the Society of Virology: abstracts (P 267).
Details anzeigen

Pilchová, V., Prajeeth, C. K., Jendrny, P., Twele, F., Meller, S., Pink, I., Fathi, A., Addo, M. M., Volk, H. A., Osterhaus, A., Köckritz-Blickwede, M. v., & Schulz, C. (2023). β-Propiolactone (BPL)-inactivation of SARS-Co-V-2: in vitro validation with focus on saliva from COVID-19 patients for scent dog training. Journal of Virological Methods, 317, 114733. https://doi.org/10.1016/j.jviromet.2023.114733
Details anzeigen

Pöpperl, P., Chludzinski, E., Ciurkiewicz, M., Stoff, M., Tipold, A., Ludlow, M., & Beineke, A. (2023). Makrophagen gehen viral: Untersuchung zur peripheren angeborenen Immunantwort bei der Hundestaupevirus-Infektion. In Tierärztliche Praxis / K (P11). Thieme. https://doi.org/10.1055/s-0043-1770879
Details anzeigen

Roper, R. L., Garzino-Demo, A., Del Rio, C., Bréchot, C., Gallo, R., Hall, W., Esparza, J., Reitz, M., Schinazi, R. F., Parrington, M., Tartaglia, J., Koopmans, M., Osorio, J., Nitsche, A., Huan, T. B., LeDuc, J., Gessain, A., Weaver, S., Mahalingam, S., et al. (2023). Monkeypox (Mpox) requires continued surveillance, vaccines, therapeutics and mitigating strategies. Vaccine, 41(20), 3171–3177. https://doi.org/10.1016/j.vaccine.2023.04.010
Details anzeigen

Rosiak, M., Hülskötter, K., Beythien, G., Allnoch, L., Becker, K., Clever, S., Schünemann, L., Meyer zu Natrup, C., Tscherne, A., Limpinsel, L., Tuchel, T., Sutter, G., Volz, A., Baumgärtner, W., & Ciurkiewicz, M. (2023). Immunisierung mit MVA-Vektorimpfstoffen schützt K18-hACE2 Mäuse vor SARS- CoV-2 vermittelten, pathologischen Veränderungen im ZNS. In Tierärztliche Praxis / K (P28). Thieme. https://doi.org/10.1055/s-0043-1770896
Details anzeigen

Shuhsadhe, R., Vazhayil, J., Ali, H. S., Orsud, H., & Mergani, A. E. O. (2023). Immunogenic characterization of AlPO4 adsorbed Td vaccine and liposome-mediated Td vaccine. Clinical and Experimental Vaccine Research: Official Publication of Korean Vaccine Society, 12(3), 232–239. https://doi.org/10.7774/cevr.2023.12.3.232
Details anzeigen

Stanelle-Bertram, S., Beck, S., Mounogou, N. K., Schaumburg, B., Stoll, F., Al Jawazneh, A., Schmal, Z., Bai, T., Zickler, M., Beythien, G., Becker, K., de le Roi, M., Heinrich, F., Schulz, C., Sauter, M., Krasemann, S., Lange, P., Heinemann, A., van Riel, D., et al. (2023). CYP19A1 mediates severe SARS-CoV-2 disease outcome in males. Cell Reports. Medicine, 4(9), Article 101152. https://doi.org/10.1016/j.xcrm.2023.101152
Details anzeigen

Stegmann, C., Zapatero Belinchón, F. J., van Ham, M., Arroyo-Fernandez, L., Bi, W., Möller, R., Jänsch, L., Kalderali, L., & Gerold, G. (2023). Mapping of early chikungunya virus: host cell interactions by proximity labeling mass spectrometry. In 32nd Annual Meeting of the Society of Virology: abstracts (O 092).
Details anzeigen